A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

Clinical trial NCT04746924 · TERMINATED

Trial details

NCT number: NCT04746924
Sponsor: BeiGene
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer NSCLC

Start date: 2021-05-24
Primary completion: 2025-05-30
Enrollment: 669

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.